Brief: Archrock Q4 Adjusted EBITDA USD 269.4 Million Vs. IBES Estimate USD 210.9 Million
24/02/2026 21:15
Feb 24 (Reuters) - Archrock Q4 revenue USD 377.1 million vs. IBES estimate USD 378.9 million. Q4 net income USD 116.8 million
Recent news on Archrock
See all newsArchrock Q1 revenue rises but misses estimates, EBITDA beats
Brief: Archrock Q1 Adjusted EBITDA USD 221 Million Vs. IBES Estimate USD 216.6 Million
U.S. RESEARCH ROUNDUP- Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
Gas compression services firm Archrock's Q4 revenue slightly misses estimates
Brief: Archrock Q4 Adjusted EBITDA USD 269.4 Million Vs. IBES Estimate USD 210.9 Million